In addition to the primary stimulus of glucose, specific amino acids may acutely and chronically regulate insulin secretion from pancreatic β-cells in vivo and in vitro. Mitochondrial metabolism is crucial for the coupling of glucose, alanine, glutamine and glutamate recognition with exocytosis of insulin granules. This is illustrated by in vitro and in vivo observations discussed in the present review. Mitochondria generate ATP (the main coupling messenger in insulin secretion) and other factors that serve as sensors for the control of the exocytotic process. The main factors that mediate the key amplifying pathway over the Ca 2+ signal in nutrient-stimulated insulin secretion are nucleotides (ATP, GTP, cAMP and NADPH), although metabolites have also been proposed, such as long-chain acyl-CoA derivatives and glutamate. In addition, after chronic exposure, specific amino acids may influence gene expression in the β-cell, which have an impact on insulin secretion and cellular integrity. Therefore amino acids may play a direct or indirect (via generation of putative messengers of mitochondrial origin) role in insulin secretion.
Introduction
The endocrine islets of Langerhans contain four major cell types: insulin-secreting β-cells, glucagon-secreting α-cells, somatostatin-releasing δ-cells and pancreatic polypeptideproducing cells. Nutrients, hormones and neurotransmitters influence the secretion of insulin but the major physiological regulator is glucose. Amino acids can, under appropriate conditions, enhance insulin secretion from primary islet β-cells and β-cell lines [1] [2] [3] [4] [5] . In vivo, L-glutamine and L-alanine are quantitatively the most abundant amino acids in the blood and extracellular fluids, followed closely by the branched chain amino acids [6] . However, unlike glucose, individual amino acids do not provoke insulin secretion in vitro when added at physiological concentrations. Combinations of amino acids at physiological concentrations or high concentrations of individual amino acids are much more effective. Amino acids derived from dietary proteins in vivo and those released from intestinal epithelial cells, in combination with glucose, will elevate insulin secretion from pancreatic β-cells and, as a consequence, stimulate protein synthesis and amino acid transport in target tissues such as skeletal muscle [7] . These effects occur independently of the well-characterized effects of insulin on GLUT4 translocation and glucose uptake and storage. In periods of fasting or starvation, amino acid release from skeletal muscle (primarily L-glutamine and Lalanine; [8] ) may modulate glucagon release from pancreatic α-cells, which subsequently may influence insulin secretion from β-cells. Dietary amino acids may also stimulate incretin release, e.g. GLP-1 (glucagon-like peptide 1), from intestinal L-cells [9, 10] and therefore may stimulate insulin secretion via incretin-dependent mechanisms.
Only a relatively small number of amino acids promote or synergistically enhance insulin release from pancreatic β-cells [11, 12] . The mechanisms by which amino acids enhance insulin secretion are varied. The cationically charged amino acid, L-arginine, does so by direct depolarization of the plasma membrane at neutral pH but only in the presence of glucose. However, as L-arginine is found at a very low physiological concentration in the plasma (approx. 0.07 mmol/l [6] , approx. 10-fold lower than glutamine), this mechanism is probably not relevant in vivo. Other amino acids, which are co-transported with Na + , can also depolarize the cell membrane as a consequence of Na + transport and thus induce insulin secretion by activating voltage-dependent calcium channels. Metabolism, resulting in partial oxidation, e.g. L-alanine [3] , may initially increase the cellular content of ATP, leading to closure of the ATP-sensitive K + channel, depolarization of the plasma membrane, activation of voltageactivated Ca 2+ channel, Ca 2+ influx and insulin exocytosis. Additional mitochondrial signals may be generated that have an impact on insulin secretion [13, 14] . A summary of potential regulatory mechanisms with respect to amino acid-stimulated insulin secretion is shown in Figure 1 .
Nutrient-induced insulin secretion
The β-cell is metabolically distinct from almost all other mammalian cell types in several respects: (i) it can utilize glucose in the physiologically relevant range (2-20 mmol/l) as it expresses a combination of GLUT2 (high K m glucose transporter) and glucokinase; (ii) low lactate dehydrogenase and plasma membrane mono-carboxylate pyruvate/lactate Glucose equilibrates across the plasma membrane and is metabolized via glycolysis, yielding pyruvate (Pyr), which is then metabolized further by the tricarboxylic acid cycle. Mitochondrial metabolism is also activated by amino acids such as alanine, glutamine or glutamate. The tricarboxylic acid cycle generates reducing equivalents, which are transferred to the electron transport chain, leading to generation of ATP. The rise in ATP levels leads to closure of K ATP channels and depolarizes the cell membrane. This opens voltage-dependent Ca 2+ channels, increasing [Ca 2+ ] i , which triggers insulin exocytosis. Additional metabolic signals may be generated from tricarboxylic acid cycle intermediates, which 'amplify' the initial Ca 2+ -dependent stimulation for the exocytosis of insulin. OAA, oxaloacetate.
transporter activity and correspondingly high activity in the mitochondrial malate-aspartate shuttle so ensuring mitochondrial oxidation of NADH; and (iii) a high activity of both pyruvate dehydrogenase and pyruvate carboxylase, ensuring that both anaplerotic and oxidative metabolism of glucose/pyruvate can co-exist. All these specific metabolic adaptations are geared to enhancing mitochondrial tricarboxylic acid cycle activity, oxidative phosphorylation and efficient ATP production. An enhancement of the ATP/ADP ratio results in closure of the ATP-sensitive K + channel, depolarization of the plasma membrane, opening of voltageactivated Ca 2+ channels, influx of Ca 2+ and finally fusion of insulin-containing granules with the plasma membrane [15] .
Lipid metabolism, via long-chain acyl-CoA formation, may promote insulin secretion [16, 17] . Citrate exported from the mitochondria to the cytosol is cleaved by ATP citrate lyase to generate oxaloacetate and acetyl-CoA, which subsequently forms malonyl-CoA in a reaction catalysed by ACC (acetyl-CoA carboxylase), promoting fatty acid synthesis and accumulation of long-chain acyl-CoAs [17] , thereby enhancing Ca 2+ -evoked insulin exocytosis [16] . Amino acids may also modulate lipid metabolism. ACC, responsible for malonyl-CoA synthesis, is activated by glutamate-sensitive protein phosphatase type 2A [18] , an effect demonstrated in islet β-cells [19] . ACC is also regulated by phosphorylation via AMP-regulated kinase, an enzyme sensitive to amino acid concentration [20] . Recent work in our laboratory (see below) has demonstrated that addition of 10 mmol/l L-alanine to the BRIN-BD11 β-cell line increased expression of ATP citrate lyase by 2.0-fold. ATP citrate lyase will convert citrate into acetyl-CoA in the cytosol, thus providing the key step in fatty acid synthesis, ACC, with substrate. Addition of 10 mmol/l L-glutamine to BRIN-BD11 β-cells up-regulated ACC expression at the mRNA and protein level [21] , thus stimulating fatty acid synthesis.
In the mitochondrial matrix, Ca 2+ increases the activity of several dehydrogenases. In this manner, increased cytosolic Ca 2+ occurring during cell activation is relayed to the mitochondria via a Ca 2+ uniporter [22] . Such a Ca 2+ entry is favoured by activation of the respiratory chain, for instance by glucose in the β-cell. Therefore hyperpolarization of the mitochondrial membrane permits the rise in mitochondrial Ca 2+ , further activating NADH-generating dehydrogenases [23] . The primary actions of glucose are mediated by potentiation of ATP concentration. Generation of other additive factors derived from glucose metabolism are promoted by mitochondrial Ca 2+ elevation [24] . These mechanisms are discussed in detail later in the present review, but in the first instance essential aspects of amino acid-dependent effects on gene expression and metabolism will be covered.
Amino acid-dependent gene expression in the β-cell
Amino acids may exert an influence via mTOR (mammalian target of rapamycin)-dependent stimulation of protein synthesis and, indirectly, gene expression. Amino acid starvation can lead to tRNA accumulation, transcriptional factor activation and up-regulation of several genes that are involved in amino acid synthesis [25] . Interestingly, supra-physiological concentrations of amino acids have been shown to regulate gene expression in hepatocytes via cell swelling-dependent events [26] .
Expression of genes related to β-cell signal transduction, metabolism and apoptosis are chronically regulated by L-alanine. Analysis performed using the Affymetrix rat genome RGU34A microarray revealed that a total of 66 genes increased 1.8-fold or greater after 24 h culture with L-alanine [27] . These genes were grouped according to molecular function, and increased expression of some key metabolic genes including ATP citrate lyase and catalase was confirmed by real-time PCR. L-Alanine and L-glutamine-dependent regulation of β-cell gene expression has been reviewed recently [28] .
It is known that L-glutamine specifically regulates proinflammatory cytokine gene expression in mononuclear cells of the immune system, as well as specific functional genes in the liver, kidney, muscle, lymphocytes, adipocytes, fibroblasts and tumour cells [29] . In the context of the work described here, while L-glutamine only weakly stimulated insulin secretion from BRIN-BD11 β-cells at basal (1.1 mmol/l) glucose [12] , the amino acid was actively metabolized by several different pathways [30] . More recently, we have discovered that 10 mmol/l L-glutamine increased the chronic 24 h insulin secretion rate of this clonal β-cell line by 30% compared with 1 mmol/l glutamine, which was associated with up-regulation of 148 genes at least 1.8-fold and down-regulation of 18 genes [21] . Notably, BRIN-BD11 cells (in common with all transformed cell lines) required exposure to L-glutamine at a minimum concentration of 1 mmol/l, to avoid significant loss of viability during a chronic period of culture.
We additionally observed that 24 h exposure to Lglutamine strongly up-regulated both the calcineurin catalytic and regulatory subunit mRNA expression in BRIN-BD11 β-cells [21] . Calcineurin, or protein phosphatase 2B, is a calcium-binding protein that has been shown to contribute to the mechanism of somatostatin-induced inhibition of exocytosis in mouse pancreatic β-cells [31] . However, calcineurin has recently been identified as a key activator of NFAT (nuclear factor of activated T-cells) signalling in pancreatic β-cells. NFAT dephosphorylation and activation promotes the expression of cell cycle regulators and increases β-cell proliferation and mass. Additionally, NFAT activation induces the expression of genes, including metabolic enzymes, critical for β-cell endocrine function. Indeed, mutation of these calcineurin/NFAT-dependent genes results in hereditary forms of monogenic Type 2 diabetes [32] .
In addition, it is now appreciated that the CREB (cAMP-response-element-binding protein) transcription factor regulates specific pro-survival genes in the β-cell. CREB translocation to the nucleus is regulated by specific Ca 2+ -dependent dephosphorylation of TORC (transducers of regulated CREB) by calcineurin [33] . We also determined significant glutamine-dependent up-regulation of PDX-1 (pancreatic duodenal homeobox-1) and ACC at the mRNA level. Elevated PDX-1 transcriptional binding was confirmed by an EMSA, and increased ACC protein expression was demonstrated by Western blotting [21] . Thus glutamine may be required for the optimal in vivo and in vitro differentiation of pancreas-derived stem cells towards the β-cell phenotype, β-cell endocrine function and optimal lipid synthesis.
In summary, while L-alanine and L-glutamine may acutely regulate insulin secretion (as described in detail below), they also play a role in regulating β-cell gene expression, which will have an impact upon the ability of the β-cell to chronically respond to nutrient availability, metabolism, hormonal stimuli and regulators of functional integrity.
Role of amino acids in NADH mitochondrial shuttles and stimulation of energy metabolism
In pancreatic β-cells, the activities of the NADH shuttles play an important role in glucose metabolism. This is as a consequence of low lactate dehydrogenase activity, resulting in β-cell dependence on NADH shuttles to regenerate cytosolic NAD + . The transport of glycolysis-derived reducing equivalents from the cytosol to the mitochondrial matrix also results in the coupling of glycolysis with mitochondrial energy metabolism. Amino acids such as apartate and glutamate play a key role in such shuttles (see Figure 2) . After transport into the mitochondria, glycolysis-derived electrons are transferred to the electron transport chain, which creates the proton electrochemical gradient driving ATP synthesis. The formation of a robust proton gradient limits the production of mitochondrial coupling factors.
In β-cells, NADH may be transported to the mitochondrial matrix by either the glycerol-phosphate or the malateaspartate shuttle [34] . Inhibition of the malate-aspartate shuttle by amino-oxycetate (which acts on transamination reactions and inhibits cytosolic NADH reoxidation) attenuated the secretory response to nutrients, thus demonstrating the dominance of this latter shuttle in the β-cell. Aralar1 is the only aspartate-glutamate transporter isoform expressed in β-cells. The function of this transporter in the malate-aspartate shuttle is illustrated in Figure 2 . Adenoviralmediated overexpression of Aralar1 in INS-1E β-cells and rat pancreatic islets enhanced glucose-evoked NAD(P)H generation, electron transport chain activity and mitochondrial ATP formation [35] . Aralar1 was demonstrated to exert its effect on insulin secretion upstream of the tricarboxylic acid The malate-aspartate shuttle is the principal mechanism for the movement of reducing equivalents in the form of NADH from the cytoplasm to the mitochondrion. Cytoplasmic malate dehydrogenase reduces oxaloacetate (OAA) to malate while oxidizing NADH to NAD + . Malate then enters the mitochondrion where the reverse reaction is carried out by mitochondrial malate dehydrogenase. Movement of mitochondrial oxaloacetate to the cytoplasm to maintain this cycle is achieved by transamination to aspartate with the amino group being donated by glutamate. The 2-oxoglutarate (α-ketoglutarate) generated leaves the mitochondrion for the cytoplasm.
cycle [35] . Indeed, the capacity of the aspartate-glutamate transporter appeared to limit NADH shuttle activity and subsequent mitochondrial metabolism. Our laboratory is now investigating the role of the Aralar1 transporter in β-cell amino acid metabolism and insulin secretion.
Mechanisms of amino acid-dependent stimulation of insulin secretion l-Glutamine
Intracellular concentrations of glutamine vary from 2 to 20 mmol/l according to cell type and extracellular concentration averages 0.7 mmol/l [29] . Glutamine promotes and maintains the function of various organs and cells such as kidney, intestine, liver, heart, neurons, lymphocytes, macrophages, neutrophils, pancreatic β-cells and white adipocytes [29] . L-Glutamine is consumed at high rates by both islets and BRIN-BD11 β-cells [4] . A high rate of protein turnover may explain the need for glutamine as it would be required for purine and pyrimidine synthesis, subsequent mRNA production and, in addition, protein synthesis. Although L-glutamine is rapidly taken up and metabolized by islets, it alone does not stimulate insulin secretion or enhance glucose-induced insulin secretion. However, activation of GDH (glutamate dehydrogenase) by addition of leucine enhances insulin secretion by increasing the entry of glutamine carbon into the tricarboxylic acid cycle [5] . It is known that glucose inhibits glutaminolysis in β-cells [36] , presumably via GTP-dependent allosteric inhibition of GDH, resulting in accumulation of L-glutamate and thus product-dependent inhibition of glutaminase, and as a result blocks leucine-stimulated insulin secretion.
The production of GABA (γ -aminobutyric acid) from glutamine [37] has been proposed as an explanation for the paradox that glutamine alone does not stimulate insulin release [38] . Under this scheme, glutamine is preferentially metabolized to GABA and L-aspartate with the release of 14 CO 2 from L-[U-
14 C]glutamine in the process. There is no oxidation of glutamine in the process and this was suggested as a reason for the poor ability of glutamine alone to induce insulin secretion.
Using 13 C-labelled glutamine and NMR spectroscopy, we showed that the major products of L-[1,2 13 C]glutamine metabolism are L- [1,2- 13 C]glutamate and L-aspartate labelled at positions C-1 and C-4 in BRIN-BD11 β-cells [34] .
L-Aspartate is formed after entry of L-glutamate into the tricarboxylic acid cycle. Additionally, the L-glutamate produced from glutamine entered the γ -glutamyl cycle and resulted in an increased production of glutathione [30] . There was no NMR-based evidence for the production of GABA under our experimental conditions. Addition of glucose caused an increase in glutamate concentration but no increase in glutamine consumption, agreeing with previous reports that glucose can inhibit glutaminolysis [30] . Using 13 C-isotopomer analysis of anaplerotic flux in INS-1 β-cells, Cline et al. [39] have demonstrated that glutamine addition increased flux through GDH, but this was not correlated with insulin secretion.
A recent paper reported that L-glutamate was released from the BRIN BD11 β-cell into the extracellular medium [21] . The quantity of glutamate released was large: indeed, based on the reported increase in extracellular and intracellular glutamate on increasing the extracellular glutamine from 1 to 10 mM (approx. 1 µmol/10 6 cells per day compared with approx. 5 nmol/10 6 cells per day respectively), glutamate was released into the extracellular medium at a rate almost 200-fold above the intracellular production rate. Although we appreciate that the acute rate of glutamate release from the β-cell (i.e. <1 h) is probably low, chronic glutamate release may cause glutamate receptor activation and desensitization of the cell to further insulinotropic signals, representing a novel autocrine mechanism for regulation of β-cell function [21] . Indeed, sublethal concentrations of pro-inflammatory cytokines significantly increased glucose consumption and glutamate export from a clonal β-cell line, suggesting a novel mechanism to explain the phenomenon of cytokinedependent inhibition of insulin secretion (A. Kiely, N.H. McClenaghan, P.R. Flatt and P. Newsholme, unpublished work; see Figure 3 ).
As glutamate is known to inhibit glucagon secretion from the pancreatic α-cell, glutamate release from the β-cell may additionally represent a novel paracrine mechanism for pancreatic islet hormone release (Figure 3 ).
Intracellular l-glutamate
Intracellular L-glutamate is the most debated amino acid with respect to stimulation of insulin secretion and the possible molecular mechanisms of its action on promotion of secretion. Maechler and Wollheim [40] proposed that Lglutamate participates in nutrient-induced stimulus-secretion coupling, as an additive factor in the amplifying pathway of glucose-stimulated insulin secretion. Confusion over the importance of glutamate in glucose-stimulated insulin secretion has arisen over the years as a result of opposing findings: total cellular glutamate levels have been reported to increase in human, mouse and rat islets as well as in clonal β-cells by some groups [3, [40] [41] [42] [43] , whereas others reported no such change [44, 45] . The finding that mitochondrial activation in permeabilized β-cells directly stimulates insulin exocytosis [24] pioneered the identification of glutamate as a putative intracellular messenger [40, 46] . It has been suggested that glutamate could be transported into secretory granules, thereby promoting Ca 2+ -dependent exocytosis [40, 46, 47] . Other support for the glutamate hypothesis arises from a study in which β-cells overexpressing L-glutamate decarboxylase showed a reduced glutamate content and a reduction in glucose-stimulated insulin secretion [41] .
Studies challenging the glutamate hypothesis reported that intracellular L-glutamate was not correlated with an increase in insulin secretion on addition of glucose to mouse or rat islets [42, 45] . However, addition of L-glutamine increased intracellular glutamate concentration but with no change in insulin section, leading the authors to argue against glutamate as a coupling factor. In addition, the authors showed that activation of GDH by BCH (2-aminobicyclo[2.2.1]heptane-2-carboxylic acid) resulted in a reduction in glutamate levels but increased insulin secretion [42] . It is possible that addition of L-glutamine as a precursor for L-glutamate may lead to saturating concentrations of L-glutamate without activation of the K ATP -dependent pathway and thus may not result in an increase in insulin secretion [43] .
l-Alanine
L-Alanine is consumed at a rate of 0.1 and 0.4 µmol/min per mg of protein in BD11 cells and islets respectively [4] . Addition of 10 mmol/l alanine at basal glucose concentrations increased insulin secretion 3-and 1.6-fold for BRIN-BD11 β-cells and islets respectively [4] . L-Alanine was also reported to be oxidized by ob/ob mouse islets [48] . In RINm5F cells, the insulinotropic action of L-alanine has been reported to be a result of co-transport with Na + , which resulted in membrane depolarization, which led to an increase in intracellular Ca 2+ [49, 50] . More recently, using 13 C NMR, L-alanine was shown to undergo substantial metabolism in BRIN-BD11 cells [3] , resulting in glutamate, aspartate and lactate production. Additionally, by use of the respiratory poison oligomycin, the metabolism and oxidation of alanine were shown to be important for its ability to stimulate insulin secretion [3] .
In contrast with our own work, others have reported that addition of L-alanine did not stimulate insulin secretion from rat islet cells alone but did in the presence of L-leucine or 2-ketoisocapraote [51] . Considering all published work, it seems that the mode of action of alanine is a combination of increased ATP production (see Figure 3) , Na + co-transport and signal transduction [51, 52] .
Prolonged exposure to alanine has previously been reported to reduce subsequent alanine-induced insulin secretion [27] . The molecular mechanisms underlying this are currently under investigation.
Homocysteine
Elevated plasma homocysteine levels have been reported in hyperinsulinaemic obese subjects and in subjects with Type 2 diabetes with pre-existing coronary vascular disease [53] . However, in newly diagnosed Type 1 diabetes patients, plasma homocysteine levels are often decreased, but on development of severe complications of diabetes (particularly renal complications) plasma homocysteine is elevated compared with normal. In contrast with all the amino acids discussed above, homocysteine has a negative impact on insulin secretion in pancreatic β-cells. A recent study has revealed that homocysteine inhibits insulin section from The production of metabolic stimulus-secretion coupling factors including ATP and glutamate is indicated.
the BRIN-BD11 cell line [54] . In particular, homocysteine caused a significant and dose-dependent inhibition of insulin secretion with initial effects at 50 µmol/l. NMR studies revealed that homocysteine caused a significant reduction in the labelling of glucose-derived, tricarboxylic acid cycledependent end-products, which may subsequently affect the triggering and potentiation of insulin secretion. The effects of homocysteine were not limited to glucose but also impaired amino acid-stimulated insulin secretion: acute incubation with homocysteine resulted in concentration-dependent inhibition of alanine-, arginine-and KIC (α-ketoisocaproic acid)-induced insulin secretion. Further studies into the mechanism of homocysteine-mediated reduction in insulin secretion should shed some light into the possible role of hyperhomocysteinaemia in the development of Type 2 diabetes.
Conclusion
Amino acid metabolism is essential to normal pancreatic β-cell function as highlighted in the present review. Acutely, key amino acids such as alanine and glutamine can regulate β-cell function and insulin secretion. The mechanisms by which these amino acids confer their regulatory effects are complex and involve both transcriptional and mitochondrial effects.
L-Glutamine metabolism is important for L-glutamate production, which may act as an important stimulus-secretion coupling factor in the presence of glucose. D-Glucose conversion into L-glutamate can occur under specific conditions of glutamine limitation, via 2-oxoglutarate involving a transamination reaction. The rate of L-glutamine metabolism appears to be especially high in the β-cell, due to optimization of mitochondrial function. Thus L-glutamine is utilized by the β-cell not only for oxidation but also for glutathione production. Glutamate may play a key role in stimulation of insulin secretion either directly or via metabolism or via its role in enhancing malate-aspartate shuttle activity. However, glutamate export may result in chronic inhibition of insulin secretion. Chronic effects of changes in amino acid concentration in vivo and in vitro on β-cell function and integrity have not yet been investigated in detail but initial experiments indicate an important role for alanine and glutamine in the regulation of β-cell lipid metabolism and signal transduction. Understanding the mechanisms by which amino acids regulate insulin secretion in vivo may reveal novel sites for targeting drugs for the therapy of Type 2 diabetes in the future.
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